Related Experiment Video
Updated: Oct 12, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
Topical Coagulant Agents
Olabisi Ololade Sheppard1, Nathan Alan Foje2
1Division of Acute Care Surgery, Department of Surgery, University of Nebraska Medical Center, 983280 Nebraska Medical Center, Omaha, NE 68198, USA.
Topical hemostatic agents are advancing with improved understanding of coagulation. This review covers current surgical hemostatic materials, their benefits, and drawbacks for life-saving care.
Area of Science:
- Surgical innovation
- Hemostasis
- Coagulation physiology
Background:
- Topical hemostatic agents are crucial in surgery.
- Advancements in understanding coagulation physiology drive development.
- Surgeons need effective hemostatic tools for critical care.
Purpose of the Study:
- To review currently available topical coagulant agents and hemostatic materials used in surgery.
- To discuss the characteristics, utility, benefits, and drawbacks of these agents.
- To inform surgeons about options for improving surgical hemostasis.
Main Methods:
- Literature review of topical hemostatic agents.
- Analysis of characteristics and utility in surgical settings.
- Evaluation of benefits and drawbacks of available agents.
Main Results:
- Various topical hemostatic agents and materials are available for surgical use.
- Each agent possesses unique characteristics influencing its utility.
- Benefits and drawbacks vary, impacting clinical application and patient outcomes.
Conclusions:
- Continued evolution of coagulation knowledge fuels development of novel hemostatic agents.
- Understanding agent properties is key to optimizing surgical hemostasis.
- Safe, affordable, and accessible hemostatic materials are essential for advancing patient care.
More Related Videos
04:56Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
Related Concept Videos
Coagulation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Colloidal precipitates
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Chemical Agents for Microbial Control
Venous Thrombosis III: Interprofessional Care